KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Entries in Affitope (2)

Thursday
Sep042014

NCT02270489

Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA (AFF009)

A Randomized, Placebo-controlled, Parallel Group, Patient-blind, Phase I Study Assessing the Safety and Exploring the Immunogenicity/Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early Multiple System Atrophy

Conditions: Multiple System Atrophy, Neurodegenerative Diseases
Sponsor: Affiris AG
Collaborators: 
University Hospital, Bordeaux; Institut National de la Santé Et de la Recherche Médicale, France; Forschungszentrum Juelich; University Hospital, Toulouse
Phase 1 

 

 

Thursday
Sep042014

NCT02267434

Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease (AFF011)

A Randomized, Placebo-controlled, Parallel Group, Patient-blinded, Multi-center, Phase I Pilot Study to Assess Tolerability and Safety of Two Doses of AFFITOPE® PD03A Formulated With Adjuvant to Patients With Early Parkinson's Disease

Condition:  Parkinson's Disease
Sponsor: AFFiRis
Collaborators:  PROSENEX Ambulatoriumbetriebs GMBH, Medical University Innsbruck, Forschungszentrum Juelich
Phase 1